{"id":24802,"date":"2020-05-15T21:36:01","date_gmt":"2020-05-16T04:36:01","guid":{"rendered":"https:\/\/lapost.us\/?p=24802"},"modified":"2020-05-15T21:36:01","modified_gmt":"2020-05-16T04:36:01","slug":"san-diegos-sorrento-therapeutics-says-antibody-shows-ability-to-block-virus","status":"publish","type":"post","link":"https:\/\/lapost.us\/?p=24802","title":{"rendered":"San Diego\u2019s Sorrento Therapeutics Says Antibody Shows Ability to Block Virus"},"content":{"rendered":"<p><a href=\"https:\/\/sorrentotherapeutics.com\/\">San Diego-based Sorrento Therapeutics Inc.<\/a> announced Friday that an antibody it is developing has shown an ability to block coronavirus infection of healthy cells in the laboratory.<\/p>\n<p>STI-1499 is one of about a dozen antibody candidates the company says has demonstrated the ability to prevent SARS-CoV-2 infection of human cells.<\/p>\n<p>Sorrento Therapeutics said STI-1499 \u201ccompletely neutralized the virus infectivity at a very low antibody dose, making it a prime candidate for further testing and development.\u201d<\/p>\n<p>The announcement came one week after the company said it was collaborating with Mount Sinai Health System to develop an \u201cantibody cocktail\u201d called COVI-SHIELD to potentially treat COVID-19.<\/p>\n<p>Sorrento Therapeutics said STI-1499 would likely be the first antibody in COVI-SHIELD, though it is also expected to be developed as a stand-alone therapy.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>San Diego-based Sorrento Therapeutics Inc. announced&#46;&#46;&#46;<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[16],"tags":[],"class_list":["post-24802","post","type-post","status-publish","format-standard","hentry","category-health"],"_links":{"self":[{"href":"https:\/\/lapost.us\/index.php?rest_route=\/wp\/v2\/posts\/24802","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/lapost.us\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/lapost.us\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/lapost.us\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/lapost.us\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=24802"}],"version-history":[{"count":1,"href":"https:\/\/lapost.us\/index.php?rest_route=\/wp\/v2\/posts\/24802\/revisions"}],"predecessor-version":[{"id":24803,"href":"https:\/\/lapost.us\/index.php?rest_route=\/wp\/v2\/posts\/24802\/revisions\/24803"}],"wp:attachment":[{"href":"https:\/\/lapost.us\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=24802"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/lapost.us\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=24802"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/lapost.us\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=24802"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}